RenovoRx Inc
RNXT
Get informed when a big investor buys or sells
+ FollowMarket Cap$34.25M
Close$
$0.36
60.3% downside
Current Fair Value
60.3% downsideOvervalued by 60.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $34.25 Million |
|---|---|
| Enterprise Value | $21.96 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.32 |
| Beta | 1 |
| Outstanding Shares | 38,032,421 |
Return
| Return on Equity | -108.91% |
|---|---|
| Return on Assets | -87.86% |
| Return on Invested Capital | -106.85% |
Valuation & Multiples
| P/E Ratio | -2.85 |
|---|---|
| PEG | -6.27 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 14.75 |
| Enterprise Value to EBIT | -1.71 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 21, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
$469,500
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
$703,750
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 24.24%▲ 6.30% |
|---|---|
| Total Invested | $8.58M▲ 25.68% |
| Investors Holding | 31▼ 2.00% |
ESG Score
No data
About RenovoRx Inc
2,021 employees